CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...